Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Fonar Corporation stock logo
FONR
Fonar
$14.88
+3.2%
$13.52
$12.00
$18.68
$92.31M0.9917,107 shs18,182 shs
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
$2.50
+0.4%
$2.53
$0.82
$3.38
$90.94M1.141.77 million shs892,475 shs
NexGel, Inc. stock logo
NXGL
NexGel
$2.40
$2.43
$1.95
$5.10
$18.37M0.5271,054 shs26,530 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$4.86
+0.8%
$4.69
$4.01
$9.33
$79.92M1.32192,935 shs91,709 shs
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Fonar Corporation stock logo
FONR
Fonar
0.00%+4.94%+3.33%+7.05%-7.58%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
0.00%+3.73%-6.72%+71.23%+150.00%
NexGel, Inc. stock logo
NXGL
NexGel
0.00%+1.69%+8.60%-16.67%+8.11%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
0.00%+2.75%+1.89%+1.89%-3.38%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Fonar Corporation stock logo
FONR
Fonar
1.7366 of 5 stars
0.03.00.00.03.30.81.9
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
1.9956 of 5 stars
3.52.00.00.02.70.00.6
NexGel, Inc. stock logo
NXGL
NexGel
1.0281 of 5 stars
0.03.00.00.03.32.50.0
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
1.9792 of 5 stars
3.63.00.00.02.50.00.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Fonar Corporation stock logo
FONR
Fonar
0.00
N/AN/AN/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
3.00
Buy$9.00260.00% Upside
NexGel, Inc. stock logo
NXGL
NexGel
0.00
N/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
3.25
Buy$11.67140.05% Upside

Current Analyst Ratings Breakdown

Latest NXGL, MBOT, FONR, and SRTS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/19/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$14.00 ➝ $10.00
4/10/2025
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$9.00 ➝ $9.00
4/4/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$12.00 ➝ $12.00
(Data available from 6/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Fonar Corporation stock logo
FONR
Fonar
$102.88M0.90$3.07 per share4.84$24.78 per share0.60
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/AN/AN/AN/A$0.17 per shareN/A
NexGel, Inc. stock logo
NXGL
NexGel
$8.69M2.11N/AN/A$0.90 per share2.67
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$41.81M1.91$0.43 per share11.25$3.41 per share1.43
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Fonar Corporation stock logo
FONR
Fonar
$10.57M$1.2511.90N/A8.19%5.31%3.97%N/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-$11.44M-$0.65N/AN/AN/AN/A-110.27%-94.20%8/13/2025 (Estimated)
NexGel, Inc. stock logo
NXGL
NexGel
-$3.28M-$0.45N/AN/A-30.80%-54.95%-27.84%8/18/2025 (Estimated)
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$6.65M$0.1048.6021.13N/A4.56%3.34%3.00%8/6/2025 (Estimated)

Latest NXGL, MBOT, FONR, and SRTS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/21/2025Q1 2025
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-$0.15-$0.08+$0.07-$0.08N/AN/A
5/15/2025Q3 2025
Fonar Corporation stock logo
FONR
Fonar
N/A$0.37N/A$0.37N/AN/A
5/15/2025Q1 2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$0.04-$0.16-$0.20-$0.16$7.23 million$8.34 million
5/13/2025Q1 2025
NexGel, Inc. stock logo
NXGL
NexGel
-$0.10-$0.09+$0.01-$0.09$2.73 million$2.81 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Fonar Corporation stock logo
FONR
Fonar
N/AN/AN/AN/AN/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/AN/AN/AN/AN/A
NexGel, Inc. stock logo
NXGL
NexGel
N/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Fonar Corporation stock logo
FONR
Fonar
N/A
10.05
9.86
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/A
16.19
16.19
NexGel, Inc. stock logo
NXGL
NexGel
0.15
1.88
1.15
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/A
8.06
5.74

Institutional Ownership

CompanyInstitutional Ownership
Fonar Corporation stock logo
FONR
Fonar
50.64%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
16.30%
NexGel, Inc. stock logo
NXGL
NexGel
2.21%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
25.30%

Insider Ownership

CompanyInsider Ownership
Fonar Corporation stock logo
FONR
Fonar
1.55%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
4.74%
NexGel, Inc. stock logo
NXGL
NexGel
20.55%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
8.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Fonar Corporation stock logo
FONR
Fonar
4806.20 million6.11 millionNot Optionable
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
2036.38 million34.65 millionOptionable
NexGel, Inc. stock logo
NXGL
NexGel
107.65 million6.08 millionNot Optionable
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
4016.44 million14.98 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Fonar stock logo

Fonar NASDAQ:FONR

$14.88 +0.46 (+3.19%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$14.82 -0.07 (-0.44%)
As of 06/27/2025 04:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company also offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters, and development and implementation of practice growth and marketing strategies. It owns and operates diagnostic imaging facilities in Florida; and manages MRI scanning facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities. FONAR Corporation was founded in 1970 and is based in Melville, New York.

Microbot Medical stock logo

Microbot Medical NASDAQ:MBOT

$2.50 +0.01 (+0.40%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$2.48 -0.02 (-0.60%)
As of 06/27/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.

NexGel stock logo

NexGel NASDAQ:NXGL

$2.40 0.00 (0.00%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$2.42 +0.02 (+0.63%)
As of 06/27/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. The company was incorporated in 2009 and is based in Langhorne, Pennsylvania.

Sensus Healthcare stock logo

Sensus Healthcare NASDAQ:SRTS

$4.86 +0.04 (+0.83%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$4.73 -0.13 (-2.76%)
As of 06/27/2025 05:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.